emocha's work on opioid treatment gets first private clinic partner - Technical.ly Baltimore

Business

Nov. 22, 2017 11:12 am

emocha’s work on opioid treatment gets first private clinic partner

Pathway Healthcare is using the Johns Hopkins spinout's platform for addiction treatment. It's initially being used in Tennessee.

emocha mobile health's team.

(Photo by Stephen Babcock)

emocha is bringing its work on opioid addiction treatment into the clinic.

Dallas-based Pathway Healthcare recently signed on to use the mobile health startup’s platform. Pathway operates a network of clinics, becoming the first private partner to use the technology. It comes as officials have called for an all-hands-on-deck approach to address the opioid crisis. A treatment center in Jackson, Tennessee, was the first to begin using the platform, according to the startup.

emocha’s platform allows medical staff to observe patients taking a drug, which is designed to help patients stay on their treatment regimen. It’s completed by video, as compared with in-person observation that is normally practiced.

The startup, which is based out of Johns Hopkins’ Fast Forward 1812 space, recently expanded into work on opioid treatment. Specifically, emocha’s platform is being used in treatment of heroin and opioid addiction with buprenorphine. The treatment can be taken at home, but healthcare professionals are often weary that patients won’t stick with it. emocha CEO Sebastian Seiguer told us earlier this year that half of patients do not stick with the treatment, so using the video platform is seen as a way to improve that stat.

Using the startup’s platform, patients can record themselves taking the treatment on their via smartphone app. There are also options to report issues, and see data on the treatment. In turn, staff at the clinic can analyze data collected by emocha through a portal.

“Patients’ daily interaction with the app gives them a direct connection to their personal Patient Care Coordinator and gives their doctor important information to tailor care plans,” said Pathway Healthcare CEO Scott Olson.

emocha’s partnership follows a $1 million seed round earlier this year as it looked to take the opioid treatment into the commercial market.

Advertisement

-30-
VIEW COMMENTS

Advertisement

Sign-up for regular updates from Technical.ly

Do NOT follow this link or you will be banned from the site!